Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: Distinct repertoire and cytokine expression

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 129-138

  Menezes, C A S ^a   Rocha, M O C ^b   Souza, P E A ^a   Chaves, A C L ^c   Gollob, K J ^d   Dutra, W O ^a,e  

^a Laboratory of Comparative Pathology   (Brazil)

^b Faculty of Medicine   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e NONE   (Brazil)

Author keywords

CD28; Chagas disease; Cytokines; Repertoire; T cells

Indexed keywords

CD28 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 3042698904     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02479.x     Document Type: Article

References (51)

1. Schofield CJ, Dias JC. A cost-benefit analysis of Chagas disease control. Mem Inst Oswaldo Cruz 1991; 86:285-95.
2. Garg N, Tarleton RL. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 2002; 70:5547-55.
3. Kumar S, Tarleton RL. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol 2001; 166:4596-603.
4. Gazzinelli RT, Oswald IP, Hieny S, James SI, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves na 1-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. European J Immunol 1992; 22:2501-6.
5. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000; 403:199-203.
6. Higuchi MD, Reis MM, Aiello VD, Benvenuti LA, Gutierrez PS, Bellotti G, Pileggi F. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 1997; 56:485-9.
7. Dutra WO, Gollob KJ, Pinto-Dias JC, Gazzinelli G, Correa-Oliveira R, Coffman RL, Carvalho-Parra JF. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 1997; 45:74-80.
8. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/ 'indeterminate' and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003; 98:407-11.
9. Michailowsky V, Luhrs K, Rocha MO, Fouts D, Gazzinelli RT, Manning JE. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect Immun 2003; 71:3165-71.
10. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002; 18:262-5.
11. Dutra WO, Martins-Filho OA, Cancado JR et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 1994; 6:499-506.
12. Reis DD, Jones EM, Tostes S, Gazzinelli G, Colley DG, McCurley T. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions, presence of TNF-alfa+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993; 43:637-44.
13. Rizzo LV, Cunha-Neto E, Teixeira AR. Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses. Mem Inst Oswaldo Cruz 1988; 83:360-2.
14. Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, Martins-Filho OA, Gazzinelli G. Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1 specific immune response. Infec Immunol 2003; 71:1185-93.
15. Mosca W, Plaja J, Gallardo E, Garcia Barrios H. Immune response in human Chagas' disease I. lymphocyte blastogenesis in chagasic patients without evidence of cardiomyopathy. Acta Cient Venez 1979; 30:401-4.
16. Dutra WO, Colley DG, Pinto-Dias JC et al. Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol 2000; 51:91-7.
17. Gazzinelli RT, Parra JF, Correa-Oliveira R, Cancado JR, Rocha RS, Gazzinelli G, Colley DG. Idiotypic/anti-idiotypic interactions in schistosomiasis and Chagas' disease. Am J Trop Med Hyg 1988; 39:288-94.
18. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996; 98:1709-12.
19. Costa RP, Gollob KJ, Rocha MO et al. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of V beta 5 expressing T cells. Scand J Immunol 2000; 51:511-9.
20. Cunha-Neto E, Moliterno R, Coelho V et al. Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas' disease cardiomyopathy patients. Parasite Immunol 1994; 16:171-9.
21. Dutra WO, Martins-Filho OA, Cancado JR, Pinto-Dias JC, Brener Z, Gazzinelli G, Carvalho JF, Colley DG. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 1996; 43:88-93.
22. Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol 1993; 150:1147-59.
23. Flynn K, Mullbacher A. Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro. Immunol Cell Biol 1996; 74:413-20.
24. Liu Z, Tugulea S, Cortesini R, Suciu-Foca N. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol 1998; 10:775-83.
25. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by Ts cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nature Immunol 2002; 3:237-43.
26. Gazzinelli G, Katz N, Rocha RS, Colley DG. Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis. J Immunol 1983; 30:2891-5.
27. Bottrel RL, Dutra WO, Martins FA et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 2001; 69:3232-9.
28. Ferreira MS. Chagas disease and immunosuppression. Mem Inst Oswaldo Cruz 1999; 94:325-7.
29. Sato MN, Yamashiro-Kanashiro EH, Tanji MM, Kaneno R, Higuchi ML, Duarte AJ. CD8+ cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats. Infect Immun 1992; 60:1024-30.
30. Cunha-Neto E, Rizzo LV, Albuquerque F et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1996; 31:133-7.
31. Arosa F. A.CD8+CD28- T cells: certainties of a prevalent human T cell subset. Immunol Cell Biol 2002; 80:1-13.
32. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Maradon G. Differentiation of human CD8 T cells, implications for in vivo persistence of CD8+CD28- cytotoxic effector clones. Int Immunol 1999; 11:229-41.
33. Horiuchi T, Hirokawa M, Kawabata Y et al. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogenic hematopoietic cell grafts and its implication in post-transplant skewing of T cell repertoire. Bone Marrow Transplant 2001; 27:731-9.
34. Wagner U, Pierer M, Kaltenhauser S, Wilke B, Seidel W, Arnold S, Hantzschel H. Clonally expanded CD4+CD28null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol 2003; 33:79-84.
35. Scheuring UJ, Sabzevari H, Theofilopoulos AN. Proliferative arrest and cell cycle regulation in CD8 (+)CD28(-) versus CD8(+)CD28 (+) T cells. Hum. Immunol 2002; 63:1000-9.
36. +T cells is induced by IL-2 receptor chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol 2000; 12:1005-13.
37. Chamberlain WD, Falta MT, Kotzin BL. Functional subsets within clonally expanded CD8 (+) memory T cells in elderly humans. Clin Immunol 2000; 94:160-72.
38. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
39. Garcia S, DiSanto J, Stockinger B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 1999; 11:163-71.
40. Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003; 52:599-607.
41. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 2000; 165:6301-7.
42. Eylar EH, Lefranc CE, Yamamura Y, Báez I, Colón-Martinez SL, Rodriguez N, Breithaupt TB. HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+CD28- T subset BMC. Immunol 2001; 2:10.
43. Shirai T, Hirose S, Okada T, Nishimura H. CD5 B cells in autoimmune disease and lymphoid malignancy. Clin Immunol Immunopathol 1991; 59:173.
44. Miyahira Y, Katae M, Kobayashi S et al. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infect Immunol 2003; 71:3131-7.
45. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/ 'indeterminate' and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003; 98:407-11.
46. Donahue JP, Ricalton NS, Behrendt CE, Rittershaus C, Calaman S, Marrack P, Kappler JW, Kotzin B. Genetic analysis of low V beta 3 expression in humans. J Exp Med 1994; 179:1701-6.
47. De Inocencio J, Choi E, Glass DN, Hirsch R. T-cell receptor repertoire differences between African Americans and Caucasians associated with the polymorphism of the TCRBV3S1 (V beta 3.1). Gene J Immunol 1995; 154:4836-41.
48. Bustamante JM, Rivarola HW, Fernandez AR, Enders JE, Fretes R, Palma JA, Paglini-Oliva PA. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Clin Sci (Lond) 2003; 104:415-20.
49. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994; 6:458-66.
50. O'Garra A, Howard M. IL-10 production by CD5 B cells. Ann NY Acad Sci 1992; 651:182-99.
51. Sad S, Kagi D, Mosmann TR. Perform and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation. J Exp Med 1996; 184:1543-7.